Senshio is a medicine used to treat moderate to severe symptoms of vulvovaginal atrophy (dryness, irritation and soreness around the genital area, and painful sexual intercourse) in women who have been through menopause. Senshio contains the active substance ospemifene.
Therapeutic Indication
Senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (VVA) in post\-menopausal women.
Therapeutic Area (MeSH)
ATC Code
G03XC05
ATC Item
N/A
Pharmacotherapeutic Group
Sex hormones and modulators of the genital system
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| ospemifene | N/A | ospemifene |
EMA Name
Senshio
Medicine Name
Senshio
Aliases
N/ANo risk management plan link.
